Skip to main content
Dx & Vx Co., Ltd. logo

Dx & Vx Co., Ltd. — Investor Relations & Filings

Ticker · 180400 ISIN · KR7180400004 KO Manufacturing
Open in API
Filings indexed 474 across all filing types
Latest filing 2023-03-13 Proxy Solicitation & In…
Country KR South Korea
Listing KO 180400

About Dx & Vx Co., Ltd.

https://www.dxvx.com/

Dx & Vx Co., Ltd. is a bio-healthcare company specializing in diagnostics and vaccine development. Its diagnostics division offers molecular diagnostic solutions, genomics and bioinformatics services, and customized companion diagnostics (CDx), leveraging an AI-based genome analysis platform. The company's therapeutic pipeline is centered on an innovative mRNA vaccine platform designed for long-term storage at room temperature. Key development areas include vaccines for infectious diseases, immuno-therapeutic cancer vaccines, oral treatments for obesity, and therapies for eye conditions. Additionally, Dx & Vx provides contract development, manufacturing, and sales organization (CDMO/CSO) services and commercializes microbiome-based products and health supplements.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit proxies from shareholders for an upcoming Annual General Meeting (AGM). It contains details about the meeting, the agenda, and the proxy solicitation process. This falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for DXVX. It outlines the date, location, and agenda items (such as financial statement approval, director/auditor appointments, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2023-03-06 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (DXVX) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for material financial changes. It provides key financial highlights (revenue, operating profit, net income) and the reasons for the change, but it is not a full annual report or a conference call transcript. It fits the definition of an Earnings Release (ER) as it provides the initial announcement of financial results and key highlights. FY 2022
2023-02-08 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for DXVX, detailing key financial metrics like revenue, operating profit, and net income for the fiscal year 2022 compared to 2021. It is a standard preliminary financial announcement provided to investors and analysts, which fits the definition of an Earnings Release (ER). FY 2022
2023-02-08 Korean
기타시장안내(약명및영문명)
Regulatory Filings Classification · 95% confidence The document is a short notice regarding a change in the company's stock name (Korean and English abbreviations) for DXVX. It does not contain financial statements, board changes, or other specific report types. As it is a miscellaneous regulatory announcement regarding stock listing details, it falls under the RNS category.
2023-01-11 Korean
기타시장안내(코스닥시장위원회 개최 결과 및 심의속개 결정 안내)
Regulatory Filings Classification · 100% confidence The document is a short regulatory notice from the KOSDAQ market regarding a listing committee decision for the company DX&VX. It is an official announcement of a regulatory proceeding rather than a financial report, management discussion, or other specific corporate filing. Given its nature as a regulatory update regarding market listing status, it falls under the RNS (Regulatory Filings) category.
2023-01-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.